MS Research

WSU Researcher's Model Will Target Causes Of Everyday MS SymptomsMost research on multiple sclerosis focuses on the disease's infrequent-but-debilitating consequences. Now, a Wayne State University researcher is targeting MS's more annoying everyday symptoms like difficulty hearing or remembering things.
Adeona Starts Phase II Trials Of New MS DrugAdeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.